2-Methacryloyloxyethyl phosphorylcholine, usually shortened to MPC, is a synthetic monomer whose molecular structure copies the phosphorylcholine group found on the outer surface of living cell membranes. That mimicry is the whole point: when MPC is built into a polymer and applied to a medical device, the body treats the surface almost as if it were biological tissue rather than a foreign object. The result is dramatically less protein buildup, less clotting, less bacterial attachment, and less inflammation than you see on conventional materials. Over roughly three and a half decades of development, MPC-based polymers have moved from laboratory curiosities to components in commercially available contact lenses, cardiovascular implants, and orthopedic bearings.1Proceedings of the Japan Academy, Series B. Biomimetic polymers with phosphorylcholine groups as biomaterials for medical devices
Why a Cell-Membrane Mimic Matters
When any synthetic material enters the body, the first thing that happens is protein adsorption. Blood proteins land on the surface within seconds, and from there a cascade follows: immune cells arrive, platelets stick, bacteria colonize, and inflammation kicks in. This is the root of most biocompatibility problems with implants and devices. The outer leaflet of your cell membranes avoids triggering this cascade because it is rich in phospholipids, and the dominant polar head group on those phospholipids is phosphorylcholine. The cells your blood flows past every day are essentially coated in a phosphorylcholine layer, which is why the body does not attack its own vessel walls under normal conditions.
MPC was designed to replicate that molecular feature. It carries the same phosphorylcholine group as the natural phospholipid, attached to a methacrylate backbone that allows it to be polymerized and grafted onto surfaces or blended into bulk materials.2PubMed Central. Biomimetic phosphorylcholine polymers: 35 years of development from discovery to clinical applications The phosphorylcholine head group is zwitterionic, meaning it carries both a positive and a negative charge within the same small molecular unit. Those paired charges attract water molecules intensely, forming a tightly bound hydration layer at the surface. This hydration layer is what does most of the work: proteins and cells trying to adsorb onto the surface would first have to displace that organized water, and the energy cost of doing so is high enough that they largely cannot. The surface stays clean, not because it actively kills anything, but because it refuses to let biological material stick in the first place.
How MPC Polymers Are Made
MPC itself is a monomer, meaning it is the single building-block molecule. To create useful materials, it has to be polymerized into chains or networks, and the way you do that controls the final properties. The simplest route is conventional free-radical polymerization, which produces poly(MPC) homopolymers. But for more sophisticated applications, researchers use controlled polymerization techniques that allow precise control over chain length and architecture. One well-established approach uses a method called RAFT (reversible addition-fragmentation chain transfer) polymerization, which can be run in water and produces polymers with very uniform chain lengths.3PubMed. Synthesis of well-defined amphiphilic block copolymers having phospholipid polymer sequences as a novel biocompatible polymer micelle reagent
What makes this flexibility valuable is that MPC rarely works alone. For most real-world applications, it is copolymerized with other monomers to get the right combination of properties. Need a surface coating that grips tightly to a substrate? Combine MPC with a hydrophobic monomer that anchors to the base material. Need a material that is both protein-repellent and antibacterial? Pair MPC with an antimicrobial monomer. The phosphorylcholine group provides the biocompatibility, and the co-monomers provide whatever structural, mechanical, or functional qualities the application demands. This modular approach is a big part of why MPC has found its way into so many different medical fields.
MPC can also be grafted directly onto existing device surfaces without rebuilding the device from scratch. For instance, researchers have used ultraviolet light to initiate graft polymerization of MPC onto PEEK (a tough engineering polymer used in spinal implants and other load-bearing devices), creating a thin nanometer-scale phosphorylcholine layer without requiring separate chemical initiators.4PubMed. Self-initiated surface graft polymerization of 2-methacryloyloxyethyl phosphorylcholine on poly(ether ether ketone) by photoirradiation The light generates radicals from the PEEK structure itself, which then drive the polymerization. Approaches like this let manufacturers add MPC biocompatibility to materials that already have the right mechanical strength.
Contact Lenses and Ocular Comfort
One of the most consumer-facing uses of MPC is in silicone hydrogel contact lenses. Silicone hydrogels are excellent at letting oxygen through to the cornea, but their surfaces tend to be somewhat hydrophobic, which means they attract protein deposits and can feel dry and uncomfortable over a long wearing day. MPC polymer coatings address this by transforming the lens surface into something much more hydrophilic and slippery.
Surface characterization of MPC-modified silicone hydrogel lenses shows that the polymer creates a soft gel layer on the lens surface. Under hydrated conditions, the coefficient of friction drops by more than 80% compared to the unmodified base material, and protein deposition forces are measurably reduced.5PubMed. Surface characterization of a silicone hydrogel contact lens having bioinspired 2-methacryloyloxyethyl phosphorylcholine polymer layer in hydrated state In practical terms, the lens feels wetter and smoother against the eyelid with every blink, and the buildup of tear-film proteins over the day is suppressed. If you have worn a modern high-performance daily lens and noticed it stays comfortable well into the evening, there is a good chance that MPC-based surface chemistry is part of the reason.
Blood-Contacting Implants and Anti-Clotting Surfaces
Anywhere blood touches a synthetic surface, clotting is the central problem. Mechanical heart valves, vascular stents, and artificial lung membranes all face the risk that blood proteins will adsorb, platelets will aggregate, and a thrombus will form. Patients with these devices often take lifelong blood-thinning drugs to compensate, which carries its own bleeding risks.
MPC-based coatings offer a material-side solution. The tight hydration shell around phosphorylcholine groups makes it difficult for the plasma proteins that initiate clotting to adhere. One recent study tested a zwitterionic coating containing phosphorylcholine groups on both intravascular stents in rabbits and mechanical heart valves in sheep, and found it not only reduced foreign-body response but also prevented thrombus formation in living animals.6PubMed. Bioinspired Zwitterionic Lubrication Coating with Bridge Architecture for Anticoagulation and Endothelialization of Blood-Contacting Implants via Interfacial Force Regulation The coating also promoted endothelialization, meaning the body’s own blood-vessel lining cells grew over the coated surface, essentially helping the implant integrate naturally.
One complication worth knowing about: simply packing more phosphorylcholine groups onto a surface does not always mean better anti-clotting performance. Research into MPC-based ternary copolymer coatings found that when the density of phosphorylcholine groups was increased beyond an optimal range, anticoagulant performance actually collapsed in hypercoagulable blood, the kind seen in patients with diabetes or systemic inflammation. A composition-optimized version of the coating maintained stable anti-thrombotic performance even in these challenging conditions, including blood spiked with elevated calcium ions and bacterial endotoxins.7PubMed. Evaluation of the anti-thrombosis efficacy of MPC-based copolymer coatings in high coagulation risk blood The takeaway is that getting the formulation right matters as much as including MPC at all, especially for the sickest patients who need the technology most.
Orthopedic Joints and Wear Reduction
In hip and knee replacements, the bearing surfaces grind against each other millions of times over the implant’s life. Even tiny amounts of wear generate particles that trigger inflammatory reactions and eventually loosen the implant. Conventional cross-linked polyethylene (CLPE) liners have dramatically improved over earlier materials, but wear remains the limiting factor for implant longevity.
Grafting poly(MPC) onto the surface of CLPE liners has produced striking results in laboratory tests. The MPC-grafted surface reduces protein adsorption (which is what drives much of the adhesive friction), lowers the friction coefficient, and in some studies has achieved near-zero wear rates.8PubMed Central. Status of surface modification techniques for artificial hip implants The bond between the poly(MPC) layer and the underlying polyethylene is covalent, meaning it is chemically anchored rather than just sitting on top, which helps it withstand the mechanical loads of weight bearing. Whether “near-zero wear” in a lab translates perfectly to decades of use inside a patient is still being studied, but the direction of the data is encouraging enough that MPC-grafted joint surfaces have received serious clinical attention.
Dental Materials That Resist Biofilm
Dental restorations sit in one of the most biologically hostile environments in the body. The mouth is warm, wet, constantly bathed in bacteria, and anything bonded to a tooth is under mechanical stress from chewing. Secondary caries, meaning new decay around an existing filling, is the most common reason restorations fail, and it starts with bacterial biofilm forming at the restoration margin.
MPC has been incorporated into experimental dental adhesives and composites specifically to fight this problem. In one study, adding 7.5% MPC to a dental adhesive reduced bacterial adhesion by roughly an order of magnitude compared to a conventional adhesive, across total microorganisms, total streptococci, and the cavity-causing species Streptococcus mutans.9PubMed Central. Novel protein-repellent dental adhesive containing 2-methacryloyloxyethyl phosphorylcholine The mechanism is the same protein-repellent effect seen in other MPC applications: bacteria adhere to surfaces primarily by first latching onto a protein film, and if proteins cannot accumulate, bacteria have nothing to grip.
Even more dramatic results came from combining MPC with a separate antibacterial monomer called DMAHDM. A dental composite containing 3% MPC and 1.5% DMAHDM achieved protein adsorption about one-tenth that of a commercial composite, and biofilm colony counts dropped by more than three orders of magnitude, meaning roughly a thousandfold reduction.10PubMed Central. Protein-repellent and antibacterial dental composite to inhibit biofilms and caries This dual approach worked significantly better than either component alone. The same strategy was extended to Class V restorations (the fillings placed near the gum line, where periodontitis-related bacteria are the concern), showing major reductions in biofilms of four periodontal pathogens without compromising the material’s mechanical properties.11PubMed. A protein-repellent and antibacterial nanocomposite for Class-V restorations to inhibit periodontitis-related pathogens These materials are not yet standard in dental offices, but they represent a significant shift from the idea that fillings are inert plugs toward the concept of bioactive restorations that actively discourage disease.
Drug Delivery and Longer Circulation
When you inject a drug-loaded nanoparticle into the bloodstream, the immune system spots it almost immediately. Proteins called opsonins coat the particle’s surface, flagging it for removal by the liver and spleen. The particle might be cleared within minutes, long before it reaches a tumor or other target tissue. For decades, the standard solution has been to coat nanoparticles with polyethylene glycol (PEG), which slows immune recognition and extends circulation time. MPC-based coatings are emerging as an alternative that may outperform PEG in some situations.
Star-branched copolymer nanocarriers with a dense MPC shell have demonstrated a plasma half-life of about 19 hours in animal experiments, and their accumulation at tumor sites was more than twice that of PEG-coated particles at the same time point after injection.12Materials Chemistry and Physics. Synthesis of star-branched PLA-b-PMPC copolymer micelles as long blood circulation vectors to enhance tumor-targeted delivery of hydrophobic drugs in vivo A separate comparison using a different polymer architecture found that MPC-coated micelles were more effectively taken up by tumor cells and showed both longer circulation times and greater tumor-site accumulation than their PEG-coated equivalents.13PubMed. In vitro and in vivo anti-tumor efficiency comparison of phosphorylcholine micelles with PEG micelles
Why would MPC outperform PEG? Part of the answer may relate to a growing problem with PEG itself. Some patients develop anti-PEG antibodies after repeated exposure, which accelerates clearance of PEG-coated drugs on subsequent doses. Because MPC mimics a molecule already present on human cells, the immune system is less likely to mount a targeted response against it. The anti-fouling mechanism is also subtly different: PEG works mainly through steric repulsion (physically blocking proteins with a flexible chain), while MPC works through hydration repulsion (the tightly bound water layer makes adsorption thermodynamically unfavorable). Both approaches reduce protein binding, but the hydration-based strategy of MPC appears to be more robust in some biological environments.
How MPC Compares to Other Anti-Fouling Polymers
MPC is not the only game in town. Other zwitterionic polymers, including sulfobetaine methacrylate (SBMA) and carboxybetaine methacrylate (CBMA), also form hydration layers and resist protein adsorption. PEG-based materials remain the most widely used anti-fouling coatings in medicine. So how do they stack up?
One important comparison involves oxidative stability. Inside the body, reactive oxygen species generated by immune cells can attack polymer coatings. A study that grafted MPC, SBMA, CBMA, and a PEG-type polymer (POEGMA) onto sensor chips and exposed them to oxidative conditions found that the mass loss from all four polymers was driven by breakage of the anchoring segments that attach them to the surface, not by degradation of the anti-fouling groups themselves. The PEG-type polymer actually showed the lowest mass loss rate, mainly because its structure had become partially cross-linked.14ACS Publications (Langmuir). Understanding the Oxidative Stability of Antifouling Polymer Brushes This is worth keeping in perspective: oxidative stability is just one performance dimension, and the clinical advantages of MPC (cell-membrane mimicry, demonstrated blood compatibility, low immune recognition) go well beyond what a single degradation test can capture. But it highlights that no polymer coating is perfect in every condition, and the choice between MPC, PEG, and other zwitterions often depends on the specific application.
Cartilage-Like Lubrication
Healthy articular cartilage is one of the best lubricated surfaces known, with friction coefficients as low as 0.001 to 0.01 in synovial joints. When cartilage is damaged, friction rises, wear accelerates, and osteoarthritis follows. Researchers have been trying to create synthetic hydrogels that replicate cartilage’s lubrication for use as repair scaffolds, and MPC has become a key ingredient in these efforts.
A multilayer hydrogel scaffold designed to mimic cartilage’s layered architecture used an MPC-containing top layer to provide the lubrication surface. Under hydrated conditions, this scaffold achieved an interfacial friction coefficient of 0.05, which, while not matching the best native cartilage, is a remarkable number for a synthetic material and far below what an unmodified hydrogel can achieve.15PubMed. Hyaluronic acid-doped bionic multilayer hydrogel scaffolds: Synergizing mechanical and lubrication properties for articular cartilage repair A separate supramolecular hydrogel incorporating MPC reached a similarly low friction coefficient of 0.057 under physiological conditions, attributed to the phosphorylcholine groups binding water molecules so strongly that shear occurs within the water layer itself rather than between solid surfaces.16Supramolecular Materials. Super-hydrated supramolecular hydrogel with persistent minimal friction enabled by zwitterion-driven microphase separation The friction is essentially carried by water, not by the material, and this is directly analogous to how natural cartilage lubrication works.
Oral Health Beyond Fillings
MPC’s relationship with the mouth extends beyond restorative dental materials. Research on oral epithelial cells has shown that MPC polymer coatings reduce the adhesion of the periodontal pathogen Porphyromonas gingivalis by about 44% and dampen the inflammatory signaling that the bacterium normally triggers. The same MPC coating also protected oral cells from chemical irritation by cetylpyridinium chloride, an antiseptic found in many commercial mouthwashes.17PubMed Central. Anti-inflammatory and protective effects of 2-methacryloyloxyethyl phosphorylcholine polymer on oral epithelial cells The implication is that MPC is not just passively protein-repellent; it can actively modulate biological responses at tissue interfaces, reducing both infection and collateral damage from the immune response or from harsh chemicals.
The Anti-Fouling Paradox in Tissue Engineering
MPC’s extraordinary ability to repel protein adsorption and cell attachment is a strength in most medical device contexts, but it becomes a complication for tissue engineering. If you are building a scaffold that needs living cells to grow into it, migrate through it, and form new tissue, you need cells to adhere. MPC resists exactly that.
This paradox has shown up experimentally. When MPC-based hydrogels were tested for 3D cell culture and bioprinting applications, they preserved high cell viability during the photopolymerization process, meaning the material was not toxic to cells in the short term. However, after seven days of culture, cell viability dropped because the anti-fouling surface prevented cells from adhering and proliferating.18JYX Jyväskylän yliopisto. Photopolymerization of cell-laden hydrogels for tissue engineering The cells were alive but had nothing to hold onto, which is ultimately fatal for adherent cell types. Solving this problem likely requires hybrid materials that combine MPC’s biocompatibility with cell-adhesive peptide sequences in carefully defined spatial patterns, giving cells places to grip while keeping the rest of the surface biologically inert. Getting that balance right is an active area of research and one of the genuine limits of MPC as a universal biomaterial solution.